Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.38 +0.20 (+6.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Share-based Compensation (2015 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) recorded Share-based Compensation of $661,000 in Q2 2026, up 31.2% from $504,000 a year earlier and up 7.5% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Share-based Compensation (2015 - 2026) Analysis & Trends

On a TTM basis, Insight Molecular Diagnostics' Share-based Compensation came in at $2.52 million as of Jun 30, 2026, up 30.7% year-over-year; for FY2025, it came in at $2.22 million, up 26.6% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of -15.2% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $1.75 million in FY2024 (-36.5%), $2.76 million in FY2023 (-72.5%), $10.04 million in FY2022 (+46.8%) and $6.84 million in FY2021 (+35.0%).
  • Quarterly Share-based Compensation has ranged from $386,000 in Q2 2024 to $3.18 million in Q3 2022 over the past five years.
  • On a year-over-year basis, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 17.8% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 73.1% in Q4 2021, against a decline of 81.5% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $615,000 (Q1 2026), $721,000 (Q4 2025) and $521,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 82.00 Mn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 168.00 Mn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 93.00 Mn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 209.90 Mn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 125.00 Mn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 54.00 Mn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 87.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 55.00 Mn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 42.20 Mn
10 Insight Molecular Diagnostics 103.74 Mn 27.46 Mn 157,000.00 661,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661,000.00
Mar 31, 2026 615,000.00
Dec 31, 2025 721,000.00
Sep 30, 2025 521,000.00
Jun 30, 2025 504,000.00
Mar 31, 2025 473,000.00
Dec 31, 2024 499,000.00
Sep 30, 2024 450,000.00
Jun 30, 2024 386,000.00
Mar 31, 2024 418,000.00
Dec 31, 2023 484,000.00
Sep 30, 2023 608,000.00
Jun 30, 2023 834,000.00
Mar 31, 2023 834,000.00
Dec 31, 2022 2.62 Mn
Sep 30, 2022 3.18 Mn
Jun 30, 2022 2.23 Mn
Mar 31, 2022 2.01 Mn
Dec 31, 2021 1.71 Mn
Sep 30, 2021 1.85 Mn
API Access

Insight Molecular Diagnostics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMDX&period=max&api_key=YOUR_API_KEY